|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/26 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 9/22 | (2006.01) | ||
| A61K 31/495 | (2006.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 47/04 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 1108424 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00403533.3 |
| Date of filing the European patent application | 2000-12-15 | |
| (97) | Date of publication of the European application | 2001-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2005-06-01 |
| (46) | Date of publication of the claims translation | 2005-10-25 |
| (30) | Number | Date | Country code |
| 9915960 | 1999-12-17 | FR |
| (72) |
Huet de Barochez, Bruno, FR
Dauphant, Claude, FR
Wuthrich, Patrick, FR
|
| (73) |
Les Laboratoires Servier,
22, rue Garnier, 92200 Neuilly sur Seine,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Matricinė tabletė, skirta trimetazidino pailgintam atpalaidavimui po jos suvartojimo geriant |
| Matrix tablet for sustained release of trimetazidine after oral administration |
| Payment date | Validity (years) | Amount | |
| 2019-10-17 | 20 | 347.00 EUR |